IFNG and breast carcinoma: Cekic et al. reported that targeting A2BR the reduced growth of bladder and breast tumors in syngeneic mice, reduced metastases of breast cancer cells, increased tumor levels of IFN-γ, and enhanced dendritic cell activation, leading to an improved anti-tumor response [143].